Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Topical recombinant human thrombin in liver segment resection
CTR20171660Phase 2Completed
- Sponsor
- Suzhou Zelgen Biopharmaceuticals
- Start
- Jan 2018
- Modality
- Therapeutic Enzymes → Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
A Phase 2 trial of thrombin alfa in Not applicable, sponsored by Suzhou Zelgen Biopharmaceuticals. Started Jan 2018; status: completed.
02
Drugs
thrombin alfa
03
Conditions
Not applicable
Beyond the preview
Go deeper on CTR20171660.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20171660.